Delivery Order SPE2DR25D6028-SPE2DR26FASCV
Award Date 11/26/25
Potential Completion Date 12/24/25
Potential Value $22K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $31,919.22 to AmerisourceBergen Drug Corp for CIPROFLO-DEXA 7.5ML pharmaceutical product on December 8, 2025, with an ultimate completion date of January 6, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $9,981.78 to AmerisourceBergen Drug Corp for CIPROFLO-DEXA 7.5ML 1S on December 10, 2025, with an ultimate completion date of December 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is fulfilling...
- The Defense Logistics Agency awarded a delivery order valued at $12,215.36 to AmerisourceBergen Drug Corp for the supply of Ciproflo-Dexa 7.5ML on October 24, 2025. This competitively awarded, firm fixed-price contract has an ultimate completion date of November 21, 2025, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $8,775.74 to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Ciproflo-Dexa 7.5ML medication. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award status. The work is scheduled for completion by November 25, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order for $1,897.56 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The delivery order is for CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, with a completion date of February 12, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,375.68 to AmerisourceBergen Drug Corp for the supply of CIPROFLO-DEXA 7.5ML on June 18, 2025, with completion targeted for July 17, 2025. This competitive award, which included no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor,...
- The Defense Logistics Agency awarded a $20,700 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone 7.5ML medication on November 10, 2025, with completion targeted for December 9, 2025. This is a non-set-aside, competitively awarded delivery order representing a single pharmaceutical supply transaction. The award will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's headquarters and a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,645.80 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone otic suspension (7.5mL) on November 20, 2025, with completion expected by November 21, 2025. This non-set-aside, firm fixed-price delivery order represents a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle valued through...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Cipro 500 mg tablets (100-count units) at a ceiling value of $1,185.69. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by August 14, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, with a ceiling value of $1,289.58. The contract has an ultimate completion date of March 22, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this order, which is part of a larger indefinite delivery contract...